Key result
In patients with hypertriglyceridemia, the presence of metabolic syndrome was strongly associated with cardiovascular disease (OR 3.85; 95% CI 1.15-9.77; p<0.05).
Cohort (n=1,394)
Yes
Odds Ratio: 3.85 (95% CI 1.15–9.77)
p-value: p=<0.05
In patients with hypertriglyceridemia, cardiovascular disease is highly prevalent and occurs prematurely, strongly associating with metabolic syndrome and family history.
Metabolic syndrome flags higher CVD risk in hypertriglyceridemia; leaves open whether targeting it improves outcomes.
Aim: To show the main clinical features of cardiovascular diseases of patients recorded in the Spanish Registry of Hypertriglyceridemia. Materials & methods: We prospectively recruited 1394 subjects referred for management to a lipid unit due to hypertriglyceridemia (triglycerides over 200 mg/dl at least twice). Results: A total of 146 patients (10.8%) had an ischemic event on the first visit, 11.7% of men and 6.9% of women. Among patients with vascular disease, 68% had a coronary event and 28% had peripheral arterial disease. Median (interquartile range) age of onset was 50 years (45–58 years) for men and 57 years (50–66 years) for women. At least 60% of men and women had the first event under 55 or 65 years old, respectively. In multivariate analyses, a history of premature ischemic event in first-degree relatives and the presence of metabolic syndrome were the strongest factors associated with cardiovascular disease (odds ratio: 2.67; 95% CI: 1.70–4.18 and 3.85; 95% CI: 1.15–9.77, respectively; p < 0.05). Conclusion: In patients referred to a lipid unit with hypertriglyceridemia, cardiovascular disease was more prevalent than in the general population and appeared prematurely when compared with coronary heart disease registries. In addition to traditional risk factors, a positive familial history of premature vascular disease and metabolic syndrome criteria were independently associated with the presence of vascular disease.
No takes yet. Share an insight, caveat, or question.
Valdivielso et al. (2013) conducted a cohort in Hypertriglyceridemia (n=1,394). Metabolic syndrome vs. Absence of metabolic syndrome was evaluated on Cardiovascular disease (OR 3.85, 95% CI 1.15-9.77, p=<0.05). In patients with hypertriglyceridemia, the presence of metabolic syndrome was strongly associated with cardiovascular disease (OR 3.85; 95% CI 1.15-9.77; p<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: